Today marks the launch of Global Week 2026, running from October 19-24, an online, international awareness campaign led by ...
Last week’s significant research news included Revolution Medicines presenting new data on its cancer drug Rasonque in KRAS ...
"Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet ...
A US-Israeli clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms Oramed Pharma is a platform technology pioneer in the field of oral delivery solutions for ...
A Cambridge, UK-based clinical-stage biotech pioneering a proprietary class of bicyclic peptide (Bicycle) medicines targeting oncology and other high-unmet-need diseases underserved by conventional ...
The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would improve the accuracy of provider ...
A precision medicine company creating therapeutics guided by the first-ever comprehensive antigen atlas for immuno-oncology targets. The California-based therapeutics company is creating the first ...
Partner Therapeutics (PTx) is a USA-based cancer start-up that was set up in January 2018 by the former Merrimack chief executive, Robert Mulroy, and Debasish Roychowdhury, the ex-chief medical ...
GNI Group is a clinical-stage bio-pharmaceutical company focusing on major diseases prevalent in Asia, especially China and Japan. GNI Group is headquartered in Tokyo, Japan, while its major drug ...
A Canadian clinical-stage biopharmaceutical company developing next-generation targeted radioconjugates for oncology, acquired by AstraZeneca in 2024 for approximately $2 billion to accelerate the ...
US drugmaker Ironwood Pharmaceuticals, which is focused on gastrointestinal and rare diseases, has announced a leadership ...
US genetic medicines developer Estuary Biotherapeutics today announced its launch with $103 million in total committed ...